Abstract
RNA G-quadruplexes (rG4s) are RNA secondary structures, which are formed by guanine-rich sequences and have important cellular functions. Existing computational tools for rG4 prediction rely on specific sequence features and/or were trained on small datasets, without considering rG4 stability information, and are therefore sub-optimal. Here, we developed rG4detector, a convolutional neural network to identify potential rG4s in transcriptomics data. rG4detector outperforms existing methods in both predicting rG4 stability and in detecting rG4-forming sequences. To demonstrate the biological-relevance of rG4detector, we employed it to study RNAs that are bound by the RNA-binding protein G3BP1. G3BP1 is central to the induction of stress granules (SGs), which are cytoplasmic biomolecular condensates that form in response to a variety of cellular stresses. Unexpectedly, rG4detector revealed a dynamic enrichment of rG4s bound by G3BP1 in response to cellular stress. In addition, we experimentally characterized G3BP1 cross-talk with rG4s, demonstrating that G3BP1 is a bona fide rG4-binding protein and that endogenous rG4s are enriched within SGs. Furthermore, we found that reduced rG4 availability impairs SG formation. Hence, we conclude that rG4s play a direct role in SG biology via their interactions with RNA-binding proteins and that rG4detector is a novel useful tool for rG4 transcriptomics data analyses.
Original language | English |
---|---|
Pages (from-to) | 11426-11441 |
Number of pages | 16 |
Journal | Nucleic Acids Research |
Volume | 50 |
Issue number | 20 |
DOIs | |
State | Published - 11 Nov 2022 |
Bibliographical note
Publisher Copyright:© The Author(s) 2022. Published by Oxford University Press on behalf of Nucleic Acids Research.
Funding
Research in the Orenstein lab was supported by the Israel Cancer Association [20221519]; Israel Science Foundation [358/21]; Israeli Council for Higher Education (CHE) via Data Science Research Center, Ben-Gurion University of the Negev, Israel; E.H. is the Mondry Family Professorial Chair at Weizmann Institute of Science; Research in the Hornstein lab is supported by Andrea L. and Lawrence A. Wolfe Family Center for Research on Neuroimmunology and Neuromodulation; CReATe consortium and ALSA (program: 'Prognostic Value of miRNAs in Biofluids From ALS Patients'); RADALA Foundation; AFM Telethon (20576); Weizmann-Brazil Center for Research on Neurodegeneration at Weizmann Institute of Science; Minerva Foundation, with funding from the Federal German Ministry for Education and Research; ISF Legacy Heritage Fund [828/17]; Israel Science Foundation [135/16, 3497/21, 424/22, 425/22]; Target ALS [118945]; Thierry Latran Foundation for ALS Research; European Research Council under the European Union's Seventh Framework Program [[FP7/2007-2013]/ERC grant agreement number 617351]; United States-Israel Binational Science Foundation [2021181]; ERA-Net for Research Programs on Rare Diseases [eRARE FP7] via the Israel Ministry of Health; Dr Sydney Brenner and friends; Edward and Janie Moravitz; A. Alfred Taubman through IsrALS; Yeda-Sela; Yeda-CEO; Israel Ministry of Trade and Industry; Y. Leon Benoziyo Institute for Molecular Medicine; the Nella and Leon Benoziyo Center for Neurological Diseases; Kekst Family Institute for Medical Genetics; David and Fela Shapell Family Center for Genetic Disorders Research; Crown Human Genome Center; Nathan, Shirley, Philip and Charlene Vener New Scientist Fund; Julius and Ray Charlestein Foundation; Fraida Foundation; the Wolf-son Family Charitable Trust; Adelis Foundation; Merck (UK); M. Halphen; estates of F. Sherr, L. Asseof and L. Fulop; Goldhirsh-Yellin Foundation; Redhill Foundation-Sam and Jean Rothberg Charitable Trust; Dr Dvora and Haim Teitelbaum Endowment Fund; Anita James Rosen Foundation; Y.M.D. is funded by a fellowship from CNRS-WIS center for research of RNA secondary structures. Funding for open access charge: Same as funding grants. Conflict of interest statement. None declared. Research in the Orenstein lab was supported by the Israel Cancer Association [20221519]; Israel Science Foundation [358/21]; Israeli Council for Higher Education (CHE) via Data Science Research Center, Ben-Gurion University of the Negev, Israel; E.H. is the Mondry Family Professorial Chair at Weizmann Institute of Science; Research in the Hornstein lab is supported by Andrea L. and Lawrence A. Wolfe Family Center for Research on Neuroimmunology and Neuromodulation; CReATe consortium and ALSA (program: ‘Prognostic Value of miR-NAs in Biofluids From ALS Patients’); RADALA Foundation; AFM Telethon (20576); Weizmann–Brazil Center for Research on Neurodegeneration at Weizmann Institute of Science; Minerva Foundation, with funding from the Federal German Ministry for Education and Research; ISF Legacy Heritage Fund [828/17]; Israel Science Foundation [135/16, 3497/21, 424/22, 425/22]; Target ALS [118945]; Thierry Latran Foundation for ALS Research; European Research Council under the European Union’s Seventh Framework Program [[FP7/2007–2013]/ERC grant agreement number 617351]; United States–Israel Binational Science Foundation [2021181]; ERA-Net for Research Programs on Rare Diseases [eRARE FP7] via the Israel Ministry of Health; Dr Sydney Brenner and friends; Edward and Janie Moravitz; A. Alfred Taubman through IsrALS; Yeda-Sela; Yeda-CEO; Israel Ministry of Trade and Industry; Y. Leon Benoziyo Institute for Molecular Medicine; the Nella and Leon Benoziyo Center for Neurological Diseases; Kekst Family Institute for Medical Genetics; David and Fela Shapell Family Center for Genetic Disorders Research; Crown Human Genome Center; Nathan, Shirley, Philip and Charlene Vener New Scientist Fund; Julius and Ray Charlestein Foundation; Fraida Foundation; the Wolf-son Family Charitable Trust; Adelis Foundation; Merck (UK); M. Halphen; estates of F. Sherr, L. Asseof and L. Fulop; Goldhirsh-Yellin Foundation; Redhill Foundation– Sam and Jean Rothberg Charitable Trust; Dr Dvora and Haim Teitelbaum Endowment Fund; Anita James Rosen Foundation; Y.M.D. is funded by a fellowship from CNRS-WIS center for research of RNA secondary structures. Funding for open access charge: Same as funding grants. Conflict of interest statement. None declared.
Funders | Funder number |
---|---|
Anita James Rosen Foundation | |
CNRS-WIS | |
Federal German Ministry for Education and Research | |
Fraida Foundation | |
Goldhirsh-Yellin Foundation | |
Julius and Ray Charlestein Foundation | |
Redhill Foundation | |
Redhill Foundation-Sam and Jean Rothberg Charitable Trust | |
Sam and Jean Rothberg Charitable Trust | |
Weizmann-Brazil Center for Research on Neurodegeneration at Weizmann Institute of Science | |
Wolf-son Family Charitable Trust | |
Merck | |
A. Alfred Taubman Medical Research Institute | |
Fondation Thierry Latran | |
Seventh Framework Programme | |
European Commission | 617351 |
Minerva Foundation | |
United States-Israel Binational Science Foundation | 2021181 |
Israel Cancer Association | 20221519 |
Israel Science Foundation | 358/21, 135/16, 118945, 3497/21, 424/22, 425/22, 828/17 |
Ministry of Industry, Trade and Labor | |
AFM-Téléthon | 20576 |
Seventh Framework Programme | |
Council for Higher Education | |
Ministry of Health, State of Israel | |
Crown Human Genome Center |